Sensus Healthcare (SRTS) 2026 meeting backs directors, pay and 2026 auditor

Rhea-AI Filing Summary

Sensus Healthcare, Inc. reported the results of its Annual Meeting of Stockholders held on May 29, 2026. Stockholders elected incumbent Class II directors Eric Sachetta and Michael J. Sardano to three-year terms expiring in 2029.

For the director elections, Sachetta received 5,532,247 votes for, 516,567 against, 270,440 abstentions, and 5,000,719 broker non-votes. Sardano received 4,702,852 votes for, 1,346,063 against, 270,339 abstentions, and 5,000,719 broker non-votes.

Stockholders also approved, on a non-binding advisory basis, the 2025 executive compensation program, with 4,740,572 votes for, 856,128 against, 722,554 abstentions, and 5,000,719 broker non-votes. In addition, stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as independent registered public accountant for the year ending December 31, 2026, with 10,738,792 votes for, 148,466 against, and 432,715 abstentions.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Annual Meeting date: May 29, 2026 Votes for Eric Sachetta: 5,532,247 votes Votes for Michael J. Sardano: 4,702,852 votes +5 more

8 metrics

Annual Meeting date May 29, 2026 Date of Sensus Healthcare Annual Meeting

Votes for Eric Sachetta 5,532,247 votes Election as Class II director

Votes for Michael J. Sardano 4,702,852 votes Election as Class II director

Say-on-pay votes for 2025 compensation 4,740,572 votes Advisory approval of executive compensation

Say-on-pay votes against 856,128 votes Advisory vote on 2025 compensation

Auditor ratification votes for 10,738,792 votes Ratification of Carr, Riggs & Ingram, LLC for 2026

Auditor ratification votes against 148,466 votes Ratification of Carr, Riggs & Ingram, LLC

Auditor ratification abstentions 432,715 votes Ratification of independent registered public accountant

Key Terms

Annual Meeting of Stockholders, Class II directors, non-binding advisory basis, independent registered public accountant, +1 more

5 terms

Annual Meeting of Stockholders financial

"The Annual Meeting of Stockholders (the “Annual Meeting”) of Sensus Healthcare, Inc."

Class II directors financial

"Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term"

non-binding advisory basis financial

"Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers"

A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.

independent registered public accountant financial

"Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the Company’s independent registered public accountant"

broker non-votes financial

"The tabulation of votes cast was as follows ... Broker Non-Votes"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

false 0001494891 0001494891 2026-05-29 2026-05-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

____________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 29, 2026

SENSUS HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-37714		27-1647271
(State of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)
851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida				33487
(Address of principal executive offices)				(Zip Code)

Registrant's telephone number, including area code: (561) 922-5808

_________________________________________________

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SRTS	Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

SENSUS HEALTHCARE, INC.

FORM 8-K

CURRENT REPORT

Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders (the “Annual Meeting”) of Sensus Healthcare, Inc. (the “Company”) was held on May 29, 2026. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, and there was no solicitation in opposition to the Company’s solicitation. The following summarizes all matters voted on at the Annual Meeting.

1. Election of Directors. Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows:

				For		Against		Abstention		Broker Non-Votes
Eric Sachetta				5,532,247		516,567		270,440		5,000,719
Michael J. Sardano				4,702,852		1,346,063		270,339		5,000,719

2. Advisory Vote on Executive Compensation. Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2025. The tabulation of votes cast was as follows:

	For		Against		Abstention		Broker Non-Votes
	4,740,572		856,128		722,554		5,000,719

3. Auditor Appointment Ratification. Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the Company’s independent registered public accountant for the fiscal year ended December 31, 2026. The tabulation of votes cast was as follows:

	For		Against		Abstention
	10,738,792		148,466		432,715

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SENSUS HEALTHCARE, INC.
Date: June 2, 2026	By:	/s/ Javier Rampolla
		Javier Rampolla
		Chief Financial Officer

FAQ

What did Sensus Healthcare (SRTS) stockholders decide at the 2026 Annual Meeting?

Stockholders elected two incumbent Class II directors, approved 2025 executive compensation on a non-binding basis, and ratified the independent auditor for 2026. These outcomes maintain the existing board structure, pay policies, and audit relationship at Sensus Healthcare without introducing major governance changes.

Which directors were elected at Sensus Healthcare’s 2026 Annual Meeting?

Eric Sachetta and Michael J. Sardano were elected as Class II directors to terms expiring in 2029. Sachetta received 5,532,247 votes for, while Sardano received 4,702,852 votes for, with additional votes recorded against, as abstentions, and as broker non-votes.

How did Sensus Healthcare (SRTS) stockholders vote on 2025 executive compensation?

Stockholders approved the 2025 executive compensation program on a non-binding advisory basis. The vote totaled 4,740,572 for, 856,128 against, 722,554 abstentions, and 5,000,719 broker non-votes, signaling overall support for the company’s named executive officer pay practices during 2025.

Which audit firm did Sensus Healthcare stockholders ratify for fiscal 2026?

Stockholders ratified Carr, Riggs & Ingram, LLC as Sensus Healthcare’s independent registered public accountant for the year ending December 31, 2026. The ratification received 10,738,792 votes for, 148,466 against, and 432,715 abstentions, affirming continuity in the company’s external auditing relationship.

What are broker non-votes in the Sensus Healthcare 2026 Annual Meeting results?

Broker non-votes are shares held by brokers that are not voted on certain proposals when instructions are not given. For Sensus Healthcare, broker non-votes totaled 5,000,719 for director elections and the executive compensation advisory proposal, affecting quorum but not counting as votes for or against.

When was Sensus Healthcare’s 2026 Annual Meeting of Stockholders held?

The Annual Meeting of Stockholders for Sensus Healthcare, Inc. was held on May 29, 2026. At this meeting, stockholders voted on director elections, an advisory resolution on 2025 executive compensation, and ratification of the independent registered public accountant for the fiscal year ending December 31, 2026.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB